MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells.
暂无分享,去创建一个
Xiaofei Zheng | Haihong Zhang | Wei Wei | Yi Tie | Yongge Wu | Xiaofei Zheng | Hai-hong Zhang | Wei Wei | Zheng Hu | Yi Tie | Zheng Hu | Hanjing Fu | Yongge Wu | Hanjing Fu
[1] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[2] M. Nakashima,et al. Ets-1 upregulates matrix metalloproteinase-1 expression through extracellular matrix adhesion in vascular endothelial cells. , 2002, Biochemical and biophysical research communications.
[3] Jacques Ferlay,et al. Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.
[4] Y. Okada,et al. Ets-1 positively regulates expression of urokinase-type plasminogen activator (uPA) and invasiveness of astrocytic tumors. , 1999, Journal of neuropathology and experimental neurology.
[5] Y. Jiang,et al. Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1. , 2001, Biochemical and biophysical research communications.
[6] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[7] V. Sementchenko,et al. Ets target genes: past, present and future , 2000, Oncogene.
[8] B. Vandenbunder,et al. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway , 2002, Oncogene.
[9] K. Tashiro,et al. Molecular cloning and expression of human hepatocyte growth factor , 1989, Nature.
[10] T. Nakayama,et al. Expression of the Ets-1 proto-oncogene is linked to cell differentiation of human hepatocellular carcinoma. , 2002, Hepato-gastroenterology.
[11] V. Ambros. The functions of animal microRNAs , 2004, Nature.
[12] A. Wellmann,et al. The Ets‐1 transcription factor is up‐regulated together with MMP 1 and MMP 9 in the stroma of pre‐invasive breast cancer , 2001, The Journal of pathology.
[13] I. Takanami,et al. Expression of Ets-1 Is Correlated with Urokinase-Type Plasminogen Activator and Poor Prognosis in Pulmonary Adenocarcinoma , 2001, Tumor Biology.
[14] Cui Jun. The Construction of miRNA Expression Library for Human , 2007 .
[15] Tara L. Kieffer,et al. Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis , 2009 .
[16] S. Friedman,et al. Molecular diagnosis of chronic liver disease and hepatocellular carcinoma: the potential of gene expression profiling. , 2006, Seminars in liver disease.
[17] S. Thorgeirsson,et al. Comparative and integrative functional genomics of HCC , 2006, Oncogene.
[18] T. Golub,et al. Impaired microRNA processing enhances cellular transformation and tumorigenesis , 2007, Nature Genetics.
[19] B. Vandenbunder,et al. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway , 2002, Oncogene.
[20] M. Abe,et al. ETS‐1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin β3 , 1999, Journal of cellular physiology.
[21] S. Nakamura,et al. Immunohistochemical expression of Ets‐1 transcription factor and the urokinase‐type plasminogen activator is correlated with the malignant and invasive potential in meningiomas , 2000, Cancer.
[22] C. Croce,et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[23] C. Creighton,et al. Widespread deregulation of microRNA expression in human prostate cancer , 2008, Oncogene.
[24] Zheng Wang,et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] S. Yamashita,et al. Overexpression of Ets-1 transcription factor in angiosarcoma of the skin. , 2000, Pathology, Research and Practice.
[26] K. Tanaka,et al. Signal transduction and transcriptional regulation of angiogenesis. , 2000, Advances in experimental medicine and biology.
[27] A. Wellmann,et al. Invasive properties of serous human epithelial ovarian tumors are related to Ets-1, MMP-1 and MMP-9 expression. , 2001, International journal of molecular medicine.
[28] C. Sweep,et al. Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer , 2002, Oncogene.
[29] Krista A. Zanetti,et al. Identification of metastasis‐related microRNAs in hepatocellular carcinoma , 2008, Hepatology.
[30] Andrea Ventura,et al. MicroRNAs and Cancer: Short RNAs Go a Long Way , 2009, Cell.
[31] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[32] L. Gravitz. Liver cancer , 2014, Nature.
[33] P. Comoglio,et al. Control of invasive growth by hepatocyte growth factor (HGF) and related scatter factors. , 1997, Cytokine & growth factor reviews.
[34] V. Mazzaferro,et al. Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma , 2007, Hepatology.
[35] Laura Pelletier,et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations , 2008, Hepatology.
[36] X. Chen,et al. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. , 2010, Cancer research.